{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T09:12:52Z","timestamp":1715418772410},"reference-count":29,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2013]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Some cases of thrombotic microangiopathy (TMA) are refractory to plasma exchange therapy (PE) with persistence or recurrence of thrombocytopenia. We report two patients suffering from TMA of different aetiologies (associated with disseminated malignancy, typical haemolytic uraemic syndrome) with recurrent or persistent thrombocytopenia despite adequate therapy including PE. Since both patients were exposed to unfractionated heparin, heparin-induced thrombocytopenia (HIT) was suspected as a cause. Pretest probabilities for HIT were intermediate. ELISA for PF4\/heparin antibodies was strongly positive in both cases, and HIT was confirmed by heparin-induced platelet activation assay. Anticoagulation with lepirudin was initiated, with subsequent rapid increase of the platelet count.<\/jats:p><jats:p>TMA might represent a predisposition for HIT. This could be due to TMA-related platelet activation with increased PF4 release. In TMA patients exposed to heparin and with refractory or rapidly recurrent thrombocytopenia HIT should always be considered as a possible cause.<\/jats:p>","DOI":"10.5482\/hamo-13-03-0012","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T09:26:08Z","timestamp":1369819568000},"page":"160-163","source":"Crossref","is-referenced-by-count":4,"title":["Heparin-induced thrombocytopenia associated with thrombotic microangiopathy"],"prefix":"10.5482","volume":"33","author":[{"given":"I.","family":"Binet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Nair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Schanz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-D.","family":"Studt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-9343(03)00080-9","article-title":"Rapid determination of anti-heparin\/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia","volume":"114","author":"L Alberio","year":"2003","journal-title":"Am J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ajh.22091","article-title":"Systemic infections mimicking thrombotic thrombocytopenic purpura","volume":"86","author":"KK Booth","year":"2011","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jca.20226","article-title":"Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience","volume":"25","author":"KW Douglas","year":"2010","journal-title":"J Clin Apheresis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2141.2001.02704.x","article-title":"Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease","volume":"113","author":"S Fontana","year":"2001","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.lpm.2011.10.026","article-title":"Thrombotic microangiopathic syndroms associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer","volume":"41","author":"JN George","year":"2012","journal-title":"Presse Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0037-1617144","article-title":"Heparin-induced thrombocytopenia","volume":"30","author":"A Greinacher","year":"2010","journal-title":"H\u00e4mostaseologie"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.thromres.2007.11.007","article-title":"Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low molecular weight-heparin, and fondaparinux in different clinical settings","volume":"122","author":"A Greinacher","year":"2008","journal-title":"Thromb Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/rheumatology\/40.8.940","article-title":"Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus","volume":"40","author":"T G\u00fcng\u00f6r","year":"2001","journal-title":"Rheumatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1537-2995.2006.00687.x","article-title":"Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: An additional study of 57 consecutive patients, 2002-2005","volume":"46","author":"MA Howard","year":"2006","journal-title":"Transfusion"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/CCO.0b013e3280148a2f","article-title":"Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation","volume":"19","author":"K Kojouri","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETSVWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"K Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.thromres.2009.11.023","article-title":"Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis","volume":"125","author":"MA Kowalska","year":"2010","journal-title":"Thromb Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOH.0b013e328309ec62","article-title":"Current management of thrombotic thrombocytopenic purpura","volume":"15","author":"JA Hovinga Kremer","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1538-7836.2006.01904.x","article-title":"Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: comparison with other assay methods","volume":"04","author":"JA Hovinga Kremer","year":"2006","journal-title":"J Thromb Haemost"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"JA Hovinga Kremer","year":"2010","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2009-07-231506","article-title":"The severity of trauma determines the immune response to PF4\/heparin and the frequency of heparin-induced thrombocytopenia","volume":"115","author":"N Lubenow","year":"2010","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"415.","DOI":"10.1046\/j.1537-2995.2003.00336.x","article-title":"Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients","volume":"43","author":"JR McMinn","year":"2003","journal-title":"Transfusion"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.beha.2009.07.004","article-title":"Thrombotic thrombocytopenia purpura and other thrombotic microangiopathies","volume":"22","author":"JL Moake","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"98.","DOI":"10.3324\/haematol.2011.048074","article-title":"Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1291 patients","volume":"97","author":"V Nellen","year":"2012","journal-title":"Haematologica"},{"key":"ref20","first-page":"394.","article-title":"Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura","volume":"49","author":"L Nguyen","year":"2009","journal-title":"An additional study of 43 consecutive patients, 2005 to 2008. Transfusion"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1046\/j.1537-2995.2000.40080896.x","article-title":"Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome","volume":"40","author":"MA Rizv","year":"2000","journal-title":"Transfusion"},{"key":"ref22","first-page":"A18.","article-title":"Anti-ADAMTS13 inhibitor boosting during plasma exchange therapy in acquired TTP as a result of a general dysregulation of the immune response","volume":"32","author":"M Schaller","year":"2012","journal-title":"H\u00e4mostaseologie"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"M Scully","year":"2012","journal-title":"Br J Haematol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1365-2141.2003.04334.x","article-title":"Heparin-induced thrombocytopenia: pathogenesis and management","volume":"121","author":"TE Warkentin","year":"2003","journal-title":"Br J Haematol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1538-7836.2009.03735.x","article-title":"Anti-PF4\/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization","volume":"08","author":"TE Warkentin","year":"2010","journal-title":"J Thromb Haemost"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1111\/j.1538-7836.2011.04536.x","article-title":"Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis","volume":"09","author":"TE Warkentin","year":"2011","journal-title":"J Thromb Haemost"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparininduced thrombocytopenia in patients treated with low-molecular-weight-heparin or unfractionated heparin","volume":"332","author":"TE Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"TE Warkentin","year":"2000","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2141.2001.03222.x","article-title":"Plasma of patients with Upshaw-Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease activity, enhances the aggregation of normal platelets under high shear stress","volume":"115","author":"H Yagi","year":"2001","journal-title":"Br J Haematol"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.5482\/HAMO-13-03-0012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T08:57:13Z","timestamp":1715417833000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.5482\/HAMO-13-03-0012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":29,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2018,2,5]]},"published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5482\/hamo-13-03-0012","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}